Table 1.
Pair | Zygosity | Subtype | Gender | Autoantibody | Organ involvement |
---|---|---|---|---|---|
1 | MZ | dcSSc | F/F | RNA pol | JT, GI, DU, RN |
2 | MZ | dcSSc | F/F | ATA | JT, GI, DU |
3 | MZ | dcSSc | F/F | RNA pol | JT |
4 | MZ | dcSSc | F/F | RNA pol | JT, LN, RN |
5 | MZ | dcSSc | F/F | U3 | JT |
6 | DZ | dcSSc | F/F | RNA pol | JT, GI, DU |
7 | MZ | lcSSc | F/F | U1 | GI |
8 | MZ | lcSSc | F/F | PL-7 | JT, GI, LN |
9 | MZ | lcSSc | F/F | U3 | JT, GI |
10 | DZ | lcSSc | F/F | ACA | JT, DU |
11 | DZ | dcSSc | F/F | ATA | JT, GI, DU, LN |
12 | MZ | dcSSc | F/F | Unknown | JT, GI, LN |
13 | MZ | dcSSc | F/F | RNA pol | N/A |
14 | DZ | lcSSc | F/F | ACA | JT |
15 | DZ | lcSSc | F/F | RNA pol | N/A |
16 | DZ | lcSSc | F/M | ATA | N/A |
17 | DZ | lcSSc | F/F | PM-Scl | JT, GI |
18 | DZ | lcSSc | F/F | U1 | JT |
19 | MZ | lcSSc | F/F | ACA | JT, GI, DU |
20 | MZ | lcSSc | F/F | U3 | GI, DU |
21 | MZ | lcSSc | F/F | ATA | N/A |
22 | MZ | lcSSc | M/M | RNA pol | N/A |
23 | MZ | lcSSc | F/F | ACA | N/A |
24 | MZ | lcSSc | F/F | ACA | N/A |
25 | MZ | lcSSc | F/F | ACA | N/A |
26 | MZ | lcSSc | F/F | ACA | N/A |
27 | MZ | lcSSc | F/F | U1 | N/A |
MZ monozygotic, DZ dizygotic, F female, M male, ACA anticentromere, RNA pol anti-RNA polymerases, ATA anti-topoisomerase I, U1 anti-U1 RNP, U3 anti-U3 RNP, PL-7 anti-PL-7, PM-Scl anti-PM-Scl, Unknown autoantibodies did not recognize known autoantigens JT joint or tendon GI gastrointestinal, DU digital ulcers, LN lung, RN renal, N/A data not available